CC
CELG

Chicago Capital’s Celgene Corp CELG Stock Holding History

Chicago Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,756
Closed -$373K – 226
2019
Q3 		$373K Sell
3,756
-437
-10% -$41.5K 0.03% 173
2019
Q2 		$388K Sell
4,193
-340
-8% -$32.3K 0.02% 176
2019
Q1 		$428K Buy
4,533
+658
+17% +$57.5K 0.03% 160
2018
Q4 		$248K Sell
3,875
-8,370
-68% -$618K 0.02% 186
2018
Q3 		$1.1M Buy
12,245
+44
+0.4% +$3.89K 0.08% 98
2018
Q2 		$969K Buy
+12,201
New +$1.01M 0.08% 105

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Chicago Capital's CELG Position: Q4 2019 in Review

Chicago Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,756 shares — an estimated $373K sold.

Chicago Capital first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $1.1M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Chicago Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Chicago Capital sold 3,756 Celgene Corp shares in Q4 2019, an estimated $373K.
  • Chicago Capital first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
  • Chicago Capital's Celgene Corp position peaked at $1.1M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Chicago Capital's 13F filing for Q4 2019, filed 14 Jan 2020.